跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BRIDION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
BRIDION
Authorized
STANDARD
BRIDION
Merck Canada Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
a49e5371b56e8ae5
Company
Merck Canada Inc
Type
Standard
Approval Details
Approval Id
a49e5371b56e8ae5
Drug Approval Canada Name
BRIDION
Product Name
BRIDION
Status
Marketed
Status Date
2016-02-19
Original Market Date
2016-02-19
Din
02451816
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
91:00.00
Atc Original
V03AB35 SUGAMMADEX
Atc Name
v 03 ab 35
Aig Number
0157810001
Company Name
Merck Canada Inc
Company Address
16750 Route Transcanadienne, Kirkland, Quebec, Canada, H9H 4M7
Active Ingredients
SUGAMMADEX (SUGAMMADEX SODIUM)
100 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
a49e5371b56e8ae5
Type
Standard
Back to Health Canada Approvals